Announcements Trials

Browse Landscape

Phase

Phase NA 4 Phase 2 3 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1

Interventions

Cisplatin 129 Radiotherapy 94 Carboplatin 82 Fluorouracil 77 Paclitaxel 76 Cyclophosphamide 76 Gemcitabine 71 Capecitabine 66 Docetaxel 64 Doxorubicin 59 Oxaliplatin 57 Etoposide 57 Leucovorin 48 Vincristine 46 Chemotherapy, Adjuvant 42 Cytarabine 38 Dexamethasone 35 Drug Therapy 33 Bevacizumab 30 Epirubicin 29 Pemetrexed 27 Neoadjuvant Therapy 26 Irinotecan 25 Tamoxifen 24 Prednisone 23 Methotrexate 21 Rituximab 19 Vinorelbine 18 Radiotherapy, Intensity-Modulated 18 Peripheral Blood Stem Cell Transplantation 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Unknown × Hematologic Tests × Clear all

NCT01687647 2014-04-09

AMORCE-CBP

University Hospital, Caen

Phase 3 Unknown

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡